asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress



Overview | Agenda | Webcast Log In | Promotional Opportunities
Registration | Continuing Education | Grantors & Exhibitors | Travel/Hotel
Speaking Proposals | Admin | Contact Us | Past Events | Home





SIXTH ASIA PACIFIC
PHARMACEUTICAL AND
MEDICAL DEVICE
COMPLIANCE CONGRESS


ATTEND ONSITE
September 21 - 23, 2016
Shangri-La Hotel
Singapore
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months






KEYNOTE SPEAKERS

Charles Cain, JD
Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC

Graeme Gunn
Legal Analyst and Manager China Outreach, Anti-Corruption Division, OECD; Former Senior Legal Officer, Attorney-General's Department, Australia, Paris, France

Ben Morgan
Joint Head of Bribery and Corruption, UK Serious Fraud, Office, London, UK

Sophie Peresson, LLM, MA
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK

Neill Stansbury, Esq.
Co-founder and Director of the Global Infrastructure Anti-Corruption Centre, Chair, International Organization for Standardization Anti-Bribery Project Committee, Vice Chair, Anti-corruption Standing Committee, World Federation of Engineering Organization, Buckinghamshire, UK

Eric Van Oppens
Region President Asia & Russia at Alcon, a Novartis company, Former Head Asia Cluster, Novartis Pharma, Former Country President and CPO Head, Novartis South Korea, Singapore

KEYNOTE GLOBAL CHIEF COMPLIANCE OFFICER ROUNDTABLE

Dante Beccaria
Senior Vice President, Global Ethics & Business Integrity, Sanofi, Vice Chair, Code Committee Network, IFPMA, Paris, France

Angela P. Main
Vice President, Global Chief Compliance Officer & Associate General Counsel, Asia Pacific, Zimmer Biomet, Singapore

Anne Nielsen, JD, LLM
Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, New York, NY, USA

Lori Queisser
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President, Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA

FEATURING PRECONFERENCE SESSIONS
  • Compliance 101 Workshop
  • Use of Analytics to Manage Risks and Detect Fraud
PLENARY SESSIONS
  • C-Suite Keynote Address
  • Global Compliance Officer Roundtable
  • Transparency International Keynote
  • UK Serious Fraud Office Update
  • US Securities and Exchange Commission Update
  • The ISO 37001 Anti-Bribery Management Systems Standard
  • Asia Pac Regional Regulatory and Enforcement Roundtable
  • Asia Pac Compliance Code and APEC Principles Updates
  • Optimizing the Relationship with Third Parties
  • Best Practices in Medical Affairs Compliance
  • Life Sciences Compliance Challenge: Moving from Cost to Value
  • Roundtable on Creating an Ethical Culture

AND MINI SUMMITS
  • China, Hong Kong and Taiwan Compliance Roundtable
  • India Compliance Roundtable
  • Innovation in Compliance
  • Patient Support Programs Compliance Issues
  • Transactions, Partnerships and M&A Compliance Issues
  • Asia Pac Medical Device Compliance Roundtable
  • Promotional and Incentive Programs Compliance Issues
  • Asia Pac Transparency and Disclosure Updates
  • Research and Development Compliance Issues

ASIA PACIFIC PHARMA CONGRESS IS
FEATURED FACULTY

Dr. Milind Antani, MBBS, LLB
Partner in charge-Pharma & Healthcare Practice, Nishith Desai Associates, Mumbai, India

Alexander Bedenkov, MD, PhD
Asia Area Medical Director, Astra Zeneca, Former Global Medical Director, Strategic Medical Affairs, Established Products (EPD), Abbott, Singapore

Craig Brooks-Rooney
Head, Asia-Pacific, Costello Medical Singapore, Singapore

Eric Carlson, Esq.
Partner, Covington & Burling LLP, Contributing Editor, FCPA Blog, Singapore

Stacy Chai
Director, Fraud Investigation & Dispute Services, EY, Singapore

Sabrina S. K. Chan, MA, JD
Executive Director, The Hong Kong Association of the Pharmaceutical Industry (HKAPI), Hong Kong

Tom Chan, JD, LLM
Head of Legal, Greater China, Takeda (China) Holdings Co. Ltd, Shanghai, China

Chi Chen, MS
Partner, EY, Shanghai, China

Eugene Chen, Esq.
Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China

Yoo-Kyung (Karen) Choi, JD, LLM
Japan and Korea Compliance Lead, Pfizer, Seoul, Korea

Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea

Campbell Clark, LLM
Chief Ethics & Compliance Officer, Asia Pacific, Medtronic, Former General Counsel, Asia, Covidien, Singapore

Adam Dryburgh LLB, Dip LP, LLM
Associate, White Collar and Fraud Group, Hogan Lovells, Singapore

Michael Dusseau
Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA

Marc Eigner, MS, MBA
Senior Partner, Co-Founder and Head of the Technology Solutions, Polaris Solutions, New York, NY, USA

Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China

Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Singapore

Don Ferrin, PhD
Professor of Organisational Behaviour and Human Resources, Singapore Management University, Singapore

Andrew Frye, MBA
Global Head, Business Unit Healthcare, Member of Group Management, DKSH, Bangkok, Thailand

Ramon Ghosh
Director, CFI, Control Risks, Singapore

Priyanka Sharma Goswami, LLB, BCL
Advocate & Partner, Quad Law Associates, Former an Associate Counsel, Offices of Additional Solicitor General of India, New Delhi, India

Mohit Grover
Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore

Andrew Ho
Head of Ethics and Business Integrity, Australia and New Zealand, Sanofi, Former Compliance Associate, Novartis, Macquarie Park NSW, Australia

David Hodgson
Partner and Audit Advisory Global Lead, Deloitte, London, UK

Ewa Holker, JD
Head of Legal & Compliance, Asia Pacific, Ferring, Singapore

Rajiv Joshi, ICAI, ISACA, CIA, CFE
Partner, Fraud Investigation & Dispute Services, EY, Mumbai, India

Jasmine Karimi, LLM
Senior Director and Counsel, APAC, Illumina, Former President, Hong Kong Corporate Counsel Association, Singapore

Reuben Khoo, MBA
Managing Partner, FIDS ASEAN, Head of Forensic Technology & Discovery Services Asia Pacific, EY, Singapore

Sarah Kochling
Managing Principal, Blossom Consultancy Ltd., Shanghai, China

Katsumi Kojima
Head of Ethics & Business Integrity-Japan, Sanofi Japan Group, Tokyo, Japan

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China

Abdul Luheshi, MBA
Director, Life Sciences Regulatory Compliance, KPMG, Former Vice President, Health Care Compliance, Johnson & Johnson, Founding Co-chair, Asia Pacific Pharma Compliance Congress, London, UK

Andrew Martin
Principal and Head of Corporate & Securities, Baker & McKenzie, Wong & Leow, Singapore

Timothy J. McGuire, MBA
Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN

Troy Morgan, JD
Sr. Director Corporate Compliance, Japan and Asia Pacific Distributor Markets, Biogen, Former Global Ethics & Compliance Counsel, GE Healthcare, Tokyo, Japan

Alison Parkes, PhD
Vice President Compliance Emerging Markets and APAC, Smith & Nephew, Singapore

Redentor Romero, JD
Associate Director, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, AstraZeneca, Singapore

Yee Chung Seck, Esq.
Partner and Lead, Pharmaceutical and Healthcare Practices, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam

Carol Shi
Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore

Wong Chae Sing
Compliance Director, Asia, ANZ and Japan, Shire (Baxalta), Former Compliance Director Asia Area, AstraZeneca, Singapore

Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics / Compliance / Legal / Sustainability), Legal/International Compliance and Risk Management Professional, , Singapore and Delhi, India

Belinda Tan
Partner, Fraud Investigations & Dispute Resolutions, EY, Singapore

Boon Heon Tan, MSA, PhD
Managing Director, South East Asia and Korea, UCB, Hong Kong, China

Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore

Emmanuel Vignal
Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China

Jonathan Shun Wah, PCLL
Regional Compliance Director, Pfizer, Hong Kong

Mark Wanda, JD
Executive Director, Anti-Bribery/Anti-Corruption Compliance, Astellas US LLC, Former Sr. VP, Legal Affairs and GC, Sunovion, Former Sr. VP and Deputy GC, Sepracor, Chicago, IL, USA

Sow Wei Wong
Legal Counsel Research and Development Centre, at Takeda Global (Asia) Pte Ltd, Former Senior Compliance Counsel, Allergan, Singapore

Vivian W. Wu, LLB, LLM
Partner, Baker & McKenzie, Beijing, China

Jooha Yang
Regional Compliance Manager, Roche Pharma Asia Pacific, Singapore

Qi (Aaron) Yao, MA
Compliance Manager, Cordis, Former Associate Manager, Compliance, Roche, Shanghai, China

Riza Faith Ybanez, LLB
Legal and Compliance Head - Oncology Asia Pacific, South Africa, Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore

Mike Zhao
Head, Compliance China, UCB Pharma, Shanghai, China


EARLY BIRD REGISTRATION
- SAVE UP TO $600 -
Register by Friday, July 22, 2016 and save up to $600.
Click here to register.

BROCHURE NOW AVAILABLE
Click here to download
the brochure.

SPONSORED BY:


The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

COSPONSORED BY:

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.



The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

CO CHAIRS

Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore

Maija Burtmanis, LLB/BSc LLM
Healthcare Compliance Officer, Asia Pacific Medical Sciences, Johnson & Johnson, Former Associate General Counsel, Alcon Russia, Former Asia Pacific, Country Compliance Officer, Novartis SG, Singapore

Gareth Lee, LLB
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore

Maria "Maru" Quindimil, MBA
Senior Director APAC Region, GEC Risk, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines

Rhys Tee
Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore

GRANTORS:
DIAMOND


SILVER


BRONZE








CONTINUING EDUCATION CREDITS
  • Accounting Professionals: Approved for up to 18.0 NASBE CPE credits.
  • Compliance Professionals: Pending approval for Compliance Certification Board CCB Credits.
  • Attorneys: Pending approval for Pennsylvania MCLE Credit.
Click here for more information.

FOLLOW ASIA PACIFIC PHARMA CONGRESS ON




PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction


LIVE AND ARCHIVED WEBCAST PARTICIPATION
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





WEBCAST INTERFACE SAMPLE

Click here for a sample stream


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.








SIXTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

September 21 - 23, 2016
ATTEND ONSITE
Shangri-La Hotel
Singapore

OR

WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months






2016 ASIA PAC CONGRESS PLANNING COMMITTEE
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Former VP, Chief Compliance Officer, Dendreon, Former Associate General Counsel and Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA

Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea

Campbell Clark, LLM
Chief Ethics & Compliance Officer, Asia Pacific, Medtronic, Former General Counsel, Asia, Covidien, Singapore

Jill Dailey, JD, MBA
Assistant General Counsel, Asia Pacific Compliance Lead, Pfizer, New York, NY, USA

Michael Dusseau
Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA

Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China

Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International Asia, Singapore

Emmanuelle Ferrari, MBL
Head of Legal and Compliance APAC, Sandoz, Former Senior Legal Counsel, Novartis Vaccines and Diagnostics, Singapore
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Mohit Grover
Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore

Ewa Holker, JD
Head of Legal & Compliance, Asia Pacific, Ferring, Singapore

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Patrik Kronig
Head of Compliance Asia Pacific, Roche, Basel, Switzerland

Cristopher Landrito, LIB
Area Compliance Officer, APAC, Takeda Pharmaceuticals, Inc., Former Regional Compliance Officer, APAC Group Compliance, Merck Pte. Ltd., Singapore

Troy Morgan, JD
Sr. Director Corporate Compliance, Japan and Asia Pacific Distributor Markets, Biogen, Former Global Ethics & Compliance Counsel, GE Healthcare, Tokyo, Japan

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK

Katrina Reinhardt, JD
Regional Head Ethics and Compliance, Asia Pacific, Baxter Healthcare, Singapore

Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel - Southeast Asia & Taiwan, AstraZeneca Pharmaceuticals, Singapore
Carol Shi
Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore

Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics/Compliance/Legal/Sustainability), Legal/International Compliance and Risk Management Professional, Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Singapore and Delhi, India

Yuet Ming Tham, JD
Partner, Sidley Austin LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Hong Kong

Albert van Maaren
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore

Emmanuel Vignal
Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China

Jonathan Shun Wah, PCLL
Regional Compliance Director, Pfizer, Hong Kong

Genevieve Wan
Asia-Pacific Pharmaceuticals Compliance Officer, GlaxoSmithKline, Singapore

Riza Faith Ybanez, LLB
Head of Legal and Compliance, Oncology, Asia Pacific, Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Former Asia Cluster Compliance Lead, Novartis, Singapore
2016 GLOBAL PHARMA COMPLIANCE CONGRESSES

TENTH INTERNATIONAL PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 10 - 12, 2016
Hilton Warsaw Hotel and Convention Centre
Warsaw, Poland
www.InternationalPharmaCongress.com
PHARMACEUTICAL SUMMIT ON BUSINESS AND COMPLIANCE ISSUES IN MANAGED MARKETS
The Leading Forum on Pharmaceutical Market Access, Reimbursement, Pricing, and Contracting with Commercial and Government Payers
Co-located with Eighth National Medical Home, Sixth Bundled Payment Summit and Seventh National ACO Summit
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
June 8 - 9, 2016
Grand Hyatt
Washington, DC
www.PharmaManagedMarketsSummit.com
SEVENTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
October 19 - 21, 2016
Mandarin Oriental
Washington, DC
www.PharmaCongress.com

OTHER GLOBAL PHARMA CONGRESS CITIES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul

2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid

2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila


THE 2015 FIFTH ASIA PACIFIC PHARMA CONGRESS CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The 2015 Fifth Asia Pacific Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE ASIA PACIFIC PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of 2015 Fifth Asia Pacific Pharma Congress Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2015 Fifth Asia Pacific Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE ASIA PACIFIC PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).




Overview | Agenda | Webcast Log In | Promotional Opportunities
Registration | Continuing Education | Grantors & Exhibitors | Travel/Hotel
Speaking Proposals | Admin | Contact Us | Past Events | Home




© Health Care Conference Administrators
Contact Webmaster